Your search for ‘Cornerstone Research’ returned 107 results

After nearly a decade of prominence, disclosure-only settlements may be going extinct. These settlements occur in class action cases arising from the announcement of a merger or acquisition.

For decades, corporate merger and acquisition deals have been plagued by meritless claims asserting, typically, that the companies and their officers and directors have provided insufficient disclosures.

The Delaware Court of Chancery has issued another ruling on "Don’t Ask, Don’t Waive" standstill agreements.

On August 6, 2019, New York Commercial Division Justice Andrew Borrok held that the discovery stay under the Private Securities Litigation Reform Act (PSLRA)

The SEC's Division of Enforcement recently announced its Fiscal Year (FY) 2023 results, touting a record-setting year. Rather than repeat Enforcement's detailed report available here...

On March 18, 2020, the Delaware Supreme Court unanimously held in Salzberg v. Sciabacucchi, 2020 WL 1280785 (Del. Mar. 18, 2020), that federal-forum provisions...

Shareholders are filing record numbers of securities class actions against non-U.S. issuers, despite the U.S. Supreme Court's 2010 ruling in Morrison v. National Australia Bank 1...

Welcome to the August 12, 2019 edition of our Class & Collective Action Group Newsletter, a briefing on recent developments in the class and collective action space.

Plaintiffs' lawyers recently filed numerous lawsuits alleging that some of the nation's largest mutual funds breached fiduciary duties to their shareholders by failing to file claim forms to collect securities class action settlement payouts to which the funds were entitled. Whether or not meritorious, these lawsuits highlight the duties of trust officers, investment advisors, pension fund managers and other institutional fiduciaries and investors with regard to class action claims, and

Last year marked a decrease in federal securities class action filings, with plaintiffs filing 207 cases in 2025, down from 225 in 2024. However, life sciences companies remained popular targets, accounting for 47 of these filings.1 In this White Paper, we examine 2025's filing and decision trends and provide insights to help life sciences companies navigate the litigation landscape prudently.

While the past year, or even eighteen months, was short on landmark federal securities law decisions, there was significant activity on the part of private securities litigants.

The IIROC has published for comment IIROC Notice 14-0066, Margin requirements for certain cash and security borrowing and lending arrangements.

When the SEC was considering the NYSE's proposal to permit direct listings of primary offerings, one of the frequently raised difficulties related to the potential "vulnerability"...

As noted in our earlier alert concerning securities fraud litigation under Section 10(b) of the Securities Exchange Act, the spread of COVID-19 and its effect on the global economy have caused

The liability and regulatory landscape in the U.S. continues to evolve and remains one of the highest risk areas for FI/D&O insurers worldwide.

As artificial intelligence becomes central to corporate strategy, regulators and plaintiffs are increasingly targeting companies that overstate their AI capabilities—a practice known as "AI washing."

If Matt Levine has a mantra in his "Money Stuff" column on Bloomberg, it's this: everything is securities fraud. "You know the basic idea," he often says in his most acerbic voice,

On March 18, 2020, the Delaware Supreme Court issued its unanimous decision in Salzberg v. Sciabacucchi, authored by Justice Karen L. Valihura, in which it reversed the Court of Chancery...